Myomo® Signs Nationwide Payer Network Agreement with HOMELINK
Enables Myomo to Bill “In-network” with 1200 Payers CAMBRIDGE, Mass., February 19, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with HOMELINK which will enable […]
MYOMO ANNOUNCES PRICING OF PUBLIC OFFERING
CAMBRIDGE, Mass., February 11, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of an underwritten public offering of 2,143,000 shares of common stock or common stock equivalents (which includes […]
Myomo Reports Preliminary Fourth Quarter and Full Year 2019 Results
CAMBRIDGE, MA., February 6, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2019. Read more.
Myomo Not Aware of Any Developments to Account for Stock Volatility
CAMBRIDGE, Mass., February 5, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it is unaware of any developments concerning the business of the Company that could account for the recent […]
MyoPro Approved for Reimbursement by German Statutory Health Insurance
Approval To Be Determined on Case-by-Case Basis CAMBRIDGE, Mass., February 3, 2020 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that Statutory Health Insurance in Germany has approved MyoPro for patients on […]
Myomo Announces One-for-Thirty Reverse Stock Split of its Common Stock
CAMBRIDGE, M.A. January 30, 2020 — Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, […]
Myomo Announces Partnership with Hobbs Rehabilitation for UK To Provide Specialist Neurological Rehabilitation Services
CAMBRIDGE, Mass., December 16, 2019 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has formed a partnership with Hobbs Rehabilitation to provide a range of services to support MyoPro® users […]
Myomo Reports Third Quarter 2019 Results
CAMBRIDGE, Mass., November 12, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the third quarter ended September 30, 2019. Read more.
Myomo to Report Third Quarter 2019 Results on November 12, 2019
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019, after the market […]
Myomo Closes $3M Term Loan
Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones CAMBRIDGE, Mass., October 23, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the“Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term loan agreement […]